Tag: Elagolix

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Elagolix

Morgan Stanley Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $121.00

Added to Collection on: 2020-12-16 18:10:59

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Neurocrine Biosciences
Elagolix
Valbenazine
Neurocrine
Stock
Share
Short

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Downgraded by Zacks Investment Research

Added to Collection on: 2021-04-11 04:41:15

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Share
Stock
Short

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Zacks Investment Research

Added to Collection on: 2021-04-14 07:18:45

Tags for this article:

Financial markets
Financial economics
Finance
Equity securities
Stock market
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Stock
Short
Share

Click the tags to see associated articles and topics

View Article Details
Wedbush Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $107.00

Added to Collection on: 2021-05-06 11:27:45

Tags for this article:

Finance
Financial markets
Money
Stock market
Equity securities
Neurocrine Biosciences
Share trading
Financial regulation
Elagolix
Cryptocurrency
Stock
Bitcoin

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to "Overweight" by Barclays

Added to Collection on: 2021-05-12 12:56:15

Tags for this article:

Organic compounds
Financial markets
Finance
Neurocrine Biosciences
Elagolix
Valbenazine
Neurocrine
Stock
Short
Price?earnings ratio

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Announce Quarterly Sales of $279.51 ...

Added to Collection on: 2021-05-18 06:42:32

Tags for this article:

Organic compounds
Finance
Economy
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Stock
ANGI Homeservices
Securities research
Neurocrine Biosciences Inc.
Zacks Investment Research

Click the tags to see associated articles and topics

View Article Details
Myovant and Pfizer's uterine fibroids med scores FDA nod, setting up showdown with AbbVie

Added to Collection on: 2021-05-26 22:18:45

Tags for this article:

Chemical compounds
Clinical medicine
Organic compounds
GnRH antagonists
Ethers
Triketones
Progestogens
Gynaecological neoplasia
Uterine fibroid
Relugolix
Elagolix
Heavy menstrual bleeding
Myovant

Click the tags to see associated articles and topics

View Article Details
Myovant & Pfizer's MyFembree receives nod from the FDA for endometriosis

Added to Collection on: 2022-08-11 10:54:07

Tags for this article:

Hormones
Chemistry
Chemical compounds
GnRH antagonists
Ethers
Triketones
RTT
Antiandrogens
Elagolix
Endometriosis
Gonadotropin-releasing hormone antagonist
Relugolix
Pfizer

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences rejects $2.5bn takeover bid from Sumitomo Pharma

Added to Collection on: 2022-10-13 10:35:17

Tags for this article:

Hormones
Chemical compounds
Organic compounds
GnRH antagonists
Ethers
Triketones
RTT
Estranes
Elagolix
Endometriosis
Relugolix
Gonadotropin-releasing hormone antagonist
Myovant
Myovant Sciences
sumitomo pharma

Click the tags to see associated articles and topics

View Article Details
A Win for Women With Symptomatic Uterine Fibroids - Medscape

Added to Collection on: 2022-12-14 17:31:02

Tags for this article:

Hormones
Organ systems
Sex hormones
RTT
Ethers
GnRH antagonists
Triketones
Benign neoplasms
Gonadotropin-releasing hormone antagonist
Elagolix
Relugolix
Heavy menstrual bleeding

Click the tags to see associated articles and topics

View Article Details